Recall record at a glance
| Official record | F-1923-2013 |
|---|---|
| Category | Food Recalls |
| Classification | Class I |
| FDA record status | Terminated |
| Recalling firm | Healthmaxx Global Inc. |
| Report date | Oct 2, 2013 |
| Recall initiation date | Jun 10, 2013 |
| Quantity | 4139 bottles |
| Location | Hacienda Heights, CA, United States |
Official product description
MAX Brand SUPER SELENIUM 250, 180 Count Tablets Product labeling reads in part:"MAX SUPER SELENIUM 250 ***Dietary Supplement 180 Tablet***0 65176 06756 1***Manufactured in FDA Approved Facility For:HealthMax Products Co. Altadena, CA 91001***".
Why the product was recalled
In response to a FDA inspection, the firm initiated this voluntary recall of various dietary supplements due to the following problems of mislabeling: 1) product named on the label is not actual product contained; 2)ingredients listed are not actual ingredients contained.
Distribution information
CA, MD, and NY
How to read the classification
FDA Class I indicates a situation in which there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. The classification shown here comes directly from the FDA enforcement record.
Additional record details
Recall type: Voluntary: Firm initiated. Initial notification: Letter.
What to do next
If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.
About this record
Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.
FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.